vTv Therapeutics joins the oral drug market for type one diabetics
Trending menu:
-
![Coronavirus treatment: Vaccines/drugs in the pipeline for Covid-19]()
Coronavirus treatment: Vaccines/drugs in the pipeline for Covid-19
-
![Coronavirus outbreak: The countries affected]()
Coronavirus outbreak: The countries affected
-
![Potential Covid-19 vaccine to be tested in animals]()
Potential Covid-19 vaccine to be tested in animals
-
![Drugs in pre-registration phase that are expected to reach blockbuster status by 2025]()
Drugs in pre-registration phase that are expected to reach blockbuster status by 2025
-
![BMS positioned to lead in the multiple myeloma market]()
BMS positioned to lead in the multiple myeloma market
-
![Phase IV trial results show Eylea dosing schedule improvement is possible]()
Phase IV trial results show Eylea dosing schedule improvement is possible
Expert commentary & analysis from GlobalData
Coronavirus in South Korea: Covid-19 outbreak, measures and impact
Coronavirus in Singapore: Covid-19 measures and impact
Overview of infectious disease clinical trials in China
Coronavirus: Covid-19 UK outbreak, measures and impact
Most Read
Company releases
SOM Biotech: A Top Spanish Start-Up to Follow in 2020
SOM Biotech has made Sifted's list as one of the Top Spanish Start-ups to follow in 2020.
Programme SOM0208 for the Treatment of Niemann–Pick Type C Disease
Programme SOM1311 for the Treatment of Phenylketonuria
SOM1311 is a small molecule pharmacological chaperone of Phenylalanine Hydroxylase for the treatment of Phenylketonuria.
Programme SOM3355 to Treat Chorea in Huntington Sisease and Tardive Dyskinesia
Partnership Programme to Identify Drugs Effective for Therapeutic Areas of Interest
SOMAI PRO Technology is a proprietary AI-based drug discovery technology of SOM Biotech. It is...
Company whitepapers
Microstructure of Crystals in a Topical Drug Product
Malvern PanalyticalLaboratorios Planes’ Product Catalogue
Laboratorios PlanesPartnership presentation
SOM BiotechBeyond Electronic Data Capture
niAnalyticsAtreMorine: A Biotechnological / Nutraceutical product for Parkinson’s
EuroEspes BiotechnologyStudy: Pharmacokinetics of Oral Cyanocobalamin Formulated with SNAC
Emisphere TechnologiesIoT Tracking and Monitoring
OnAsset IntelligenceCompany A-Z
Clinical Trials
Medidata and Project ALS partner to develop new therapeutic strategies
Medidata, a subsidiary of Dassault Systèmes, and Project ALS have entered a research partnership in order to develop new therapeutic strategies for the treatment of...
Harbour BioMed gets FDA approval for Phase II NPC trial
MapKure, BeiGene, and SpringWorks launch Phase I cancer study
Neurimmune enrols patient in NI006 trial for ATTR cadiomyopathy
Three Ascletis Pharma coronavirus pneumonia study patients discharged
Drug Development
Novavax starts animal testing of coronavirus vaccine candidates
US-based biotechnology company Novavax has begun testing its new coronavirus vaccine candidates in animal models. The company constructed several vaccine candidates against Covid-19.
Gilead launches remdesivir’s Phase III trials in Covid-19 patients
UBC, Apeiron Biologics to trial coronavirus drug candidate in China
Moderna delivers coronavirus vaccine candidate for Phase I trial
Zelira reports positive data from cannabis trial in insomnia
Your recommended content
Measuring wellbeing programmes for impact and returns
Download a free 10 page preview of our Mergers & Acquisitions in TMT – Thematic Research 2019 Report
Go Top